Table 4.

Evaluation of the relation between blood parameters with nodule and microcalcification findings in the studied subjects

Variant	Multinodular	Solitary	p	Microcalcification (negative)	Microcalcification (positive)	p
WBC	7.35 (±1.5)	7.90 (±1.6)	0.129*	7.62 (±1.5)	7.75 (±1.8)	0.764*
Neutrophil	4.19 (±1.4)	4.82 (±1.5)	0.061*	4.54 (±1.4)	4.48 (±1.6)	0.878*
Lymphocyte	2.48 (±0.4)	2.37 (±0.5)	0.365*	2.39 (±0.5)	2.56 (±0.4)	0.225*
Monocyte	0.43 (±0.2)	0.40 (±0.1)	0.537*	0.41 (±0.2)	0.41 (±0.1)	0.856*
Platelet	257.97 (±60.7)	254.56 (±46.7)	0.778*	255.32 (±50.0)	258.82 (±61.8)	0.808*
Hemoglobin	13.42 (±1.4)	13.69 (±1.4)	0.407*	13.57 (±1.4)	13.45 (±1.3)	0.737*
CRP	2.5 (0.1–3.2)	2.3 (1.2–3.8)	0.515**	2.2 (0.8–3.3)	3.0 (0.1–5.2)	0.616**
TSH	1.7 (1.0–3.9)	1.9 (1.2–3.1)	0.690**	1.8 (1.3–3.3)	1.7 (1.1–3.7)	0.844**
Free T4	6.1 (1.3–8.8)	7.2 (3.1–9.7)	0.364**	7.2 (2.7–8.8)	7.4 (1.2–9.5)	0.826**
Free T3	4.0 (1.7–110.9)	4.0 (1.7–110.9)	0.162**	1.9 (1.3–3.7)	3.0 (1.6–26.3)	0.606**
NLR	2.7 (1.9–3.4)	2.0 (1.5–2.5)	0.027**	1.9 (1.4–2.3)	1.6 (1.3–2.1)	0.372**
PLR	101.5 (82.5–124.7)	107.1 (91.7–128.1)	0.511**	102.7 (86.1–130.8)	104.8 (81.4–118.2)	0.441**

*: P-value by One-way ANOVA test; **: P-value by Kruskal-Wallis test; WBC: White blood cell; CRP: C-reactive protein; TSH: Thyroid-stimulating hormone; NLR: Neutrophil-to-lymphocyte ratio; PLR: Platelet-to-lymphocyte ratio.